Saito M, Yamashita K, Arimura Y, Kaneto H, Okuda H, Nojima M, et al. Serum HER2 as an adjunct to assess HER2 status for advanced gastric cancer: A prospective multicenter trial (SHERLOCK). AO [Internet]. 2016 Mar. 3 [cited 2024 Jul. 30];55(3):309-17. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/25228